Point72 (DIFC)’s ProKidney PROK Stock Holding History

Point72 (DIFC)’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,200	Closed	-$5.45K	–	1731
2025 Q2	$5.45K	Buy	+9,200	New	+$7.16K	﹤0.01%	1371

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 (DIFC)'s PROK Position: Q3 2025 in Review

Point72 (DIFC) sold out of ProKidney (PROK) in Q3 2025, closing a stake of 9,200 shares — an estimated $5.45K sold.

Point72 (DIFC) first reported a position in PROK in Q2 2025 and held it in 1 quarter. The position peaked at $5.45K in Q2 2025. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

Point72 (DIFC) reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
Point72 (DIFC) sold 9,200 ProKidney shares in Q3 2025, an estimated $5.45K.
Point72 (DIFC) first reported a position in ProKidney in Q2 2025 and held it in 1 quarter.
Point72 (DIFC)'s ProKidney position peaked at $5.45K in Q2 2025.
56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.